Skip to main content
Immunovia logo

Immunovia — Investor Relations & Filings

Ticker · IMMNOV ISIN · SE0006091997 LEI · 549300KHWL6KK1XGUO81 ST Human health and social work activities
Filings indexed 378 across all filing types
Latest filing 2025-04-17 Share Issue/Capital Cha…
Country SE Sweden
Listing ST IMMNOV

About Immunovia

https://immunovia.com/

Immunovia is a diagnostics company focused on revolutionizing the early detection of pancreatic cancer. Its primary product is the PancreaSure test, a simple blood test designed to detect pancreatic cancer at Stage 1 and 2 with high accuracy. The test is intended for annual surveillance of individuals at elevated risk due to family history or genetic mutations. PancreaSure functions by detecting proteins and other biomarkers indicative of pancreatic cancer growth. The company's mission is to improve survival rates for this highly lethal cancer by enabling diagnosis at its earliest, most treatable stages, offering a convenient alternative to invasive imaging procedures.

Recent filings

Filing Released Lang Actions
Immunovia AB meddelar utfall för nyttjandet av teckningsoptioner serie TO 3
Share Issue/Capital Change Classification · 100% confidence The document is a press release announcing the outcome of a warrant exercise (serie TO 3) for Immunovia AB. It details the number of warrants exercised, the resulting number of new shares issued, the capital increase, and the dilution effect. This falls under the category of share issuance and capital changes resulting from the exercise of financial instruments.
2025-04-17 Swedish
NOTICE OF ANNUAL GENERAL MEETING IN IMMUNOVIA AB (PUBL)
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of Annual General Meeting' for Immunovia AB. It contains the agenda, proposed resolutions, details on board elections, remuneration proposals, and incentive programs to be voted on by shareholders. This document is a classic Proxy Solicitation/Information Statement, as it provides shareholders with the necessary information to vote on matters at the upcoming meeting.
2025-04-14 English
KALLELSE TILL ÅRSSTÄMMA I IMMUNOVIA AB (PUBL)
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice ('Kallelse') for an Annual General Meeting (Årsstämma) for Immunovia AB. It contains the agenda, proposals for board elections, remuneration, and various corporate resolutions (such as share issues and incentive programs). This document is the primary material provided to shareholders to prepare for the meeting, which falls under the category of Proxy Solicitation & Information Statement.
2025-04-14 Swedish
Major Shareholding Notification 2025
Major Shareholding Notification Classification · 100% confidence The document is a 'flaggningsmeddelande' (flagging notification) filed with the Swedish Financial Supervisory Authority (Finansinspektionen). It details a change in shareholding for Immunovia AB, where Avanza Bank Holding AB has crossed a 10% threshold due to the return of loaned shares. This is a classic major shareholding notification, which falls under the 'Major Shareholding Notification' category.
2025-04-08 Swedish
Major Shareholding Notification 2025
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from the Swedish Financial Supervisory Authority (Finansinspektionen) regarding a change in shareholding (flagging notification). It details the threshold crossing of Avanza Bank Holding AB's ownership in Immunovia AB. This fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels.
2025-04-07 Swedish
Annual Report (ESEF) 2024
Annual Report (ESEF) Classification · 100% confidence FY 2024
2025-04-02 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.